The Combined Action of Pyrimidines and Sulfonamides or Sulfones in the Chemotherapy of Malaria and Other Protozoal Infections (Q40015910)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002795%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

review article

1 reference

title

The combined action of pyrimidines and sulfonamides or sulfones in the chemotherapy of malaria and other protozoal infections (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002795%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

The Combined Action of Pyrimidines and Sulfonamides or Sulfones in the Chemotherapy of Malaria and Other Protozoal Infections (English)

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

27 March 2023

1 reference

W. H. Richards

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5002795

27 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=5002795

27 March 2023

publication date

1 January 1970

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002795%20AND%20SRC:MED&resulttype=core&format=json

Advances in pharmacology and chemotherapy

11 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002795%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002795%20AND%20SRC:MED&resulttype=core&format=json

11 September 2019

page(s)

121-147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5002795%20AND%20SRC:MED&resulttype=core&format=json

Preliminary field trials on a new schizonticide

11 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

THE CONTROL OF CAECAL COCCIDIOSIS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Pharmacology of New Antimalarial Drugs Sulfonamides and Trimethoprim

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Associations of various sulphonamides and pyrimethamine in the chemotherapy of caecal coccidiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

SYNERGISTIC ACTION OF SULPHAQUINOXALINE AND 2-AMINO-4-DIMETHYLAMINO-5-(4-CHLOROPHENYL)-6-ETHYLPYRIMIDINE IN CAECAL COCCIDIOSIS IN CHICKENS

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Synergism in the chemotherapy of Eimeria infections of chicks

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Treatment of experimental avian coccidiosis with a soluble combination of sulphaquinoxaline and diaveridine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Combined therapy for chloroquine-resistant, Plasmodium falciparum infection. Concurrent use of long-acting sulphormethoxine and pyrimethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Clinical trials in Plasmodium falciparum malaria with a long-acting sulphonamide

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Chloroquine-pyrimethamine-sulfisoxazole therapy of Plasmodium falciparum malaria. An alternative to quinine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The treatment of experimental toxoplasmosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Sulphadimidine, pyrimethamine and dapsone in the treatment of toxoplasmosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Quinine, pyrimethamine, and sulphorthodimethoxine: Clinical response, plasma levels, and urinary excretion during the initial attack of naturally acquired falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

THE TREATMENT OF STREPTOCOCCAL INFECTIONS IN MICE WITH 4:4'DIAMINODIPHENYLSULPHONE

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The Evaluation of Sulfonamides, Alone or in Combination with Pyrimethamine, in the Treatment of Multi-Resistant Falciparum Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Antimalarial effect of diaphenylsulfone and three sulfonamides among semi-immune Africans.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Sulfalene and trimethoprim in acute falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

THE SELECTIVE ACTION OF SULFANILAMIDE ON THE PARASITES OF EXPERIMENTAL MALARIA IN MONKEYS IN VIVO AND IN VITRO

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Tests of 2,4-diaminopyrimidines on toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Chemotherpeutic suppression and prophylaxis in Malaria. An experimental investigation undertaken by medical research teams in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Antimalarials as Antagonists of Purines and Pteroylglutamic Acid

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

2:4-diaminopyrimidines- a new series of antimalarials

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Acute toxoplasmosis. Effective treatment with pyrimethamine, sulfadiazine, leucovorin calcium, and yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Response of Plasmodium berghei to antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Effect of 2,4-diamino-5-(p-chlorophenoxy)-6-methylpyrimidine and 2,4-diamino-6,7-diphenylpteridine on chloroguanide-resistant strain of Plasmodium gallinaceum.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Sulphormethoxine in chloroquine-resistant falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Potentiation of pyrimethamine by sulphadiazine in human malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Acquired toxoplasmosis; observations on two parasitologically proved cases treated with pyrimethamine and triple sulfonamides

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Choroquine-resistant Plasmodium falciparum malaria in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The synergism between pyrimethamine and sulphadimethylpyrimidine in the control of Eimeria tenella

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

ANTIMALARIAL EFFECT OF SULPHORTHODIMETHOXINE (FANASIL)

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

TREATMENT OF ACUTE FALCIPARUM MALARIA WITH SULPHORTHODIMETHOXINE (FANASIL).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The suppression of malarial parasitaemia by pyrimethamine in combination with dapsone or sulphormethoxine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Daraprim in treatment of malaria; a study of its effects in falciparum and quartan infections in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

PYRIMETHAMINE AND SULPHADIAZINE IN TREATMENT OF MALARIA

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Observations on the action of paludrine on malarial parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Trimethoprim in Therapy of Acute Attacks of Malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Treatment of Acute Falciparum Malaria With Sulfalene and Trimethoprim

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

A Statistical Evaluation of Synergism of Folic Acid Antagonists on Experimental Plasmodium Berghei Mouse Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The chemotherapy of rodent malaria, VII

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

A virulent chloroquine-resistant strain of Plasmodium berghei berghei transmitted through Anopheles stephensi

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Antimalarial activity of sulphonamides and a sulphone, singly and in combination with pyrimethamine, against drug resistant and normal strains of laboratory plasmodia.

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The mode of action of sulphonamides, proguanil and pyrimethamine on Plasmodium gallinaceum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Treatment of trophozoite-induced Plasmodium knowlesi infection in the rhesus monkey with Trimethoprim and sulfalene

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Treatment of chloroquine-resistant Plasmodium falciparum infections in Vietnam

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The gametocytocidal action of paludrine upon infections of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

Some Successful Trials of Proseptasine as a True Causal Prophylactic Against Infection withPlasmodium Falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The action of antimalarial drugs in mice infected with Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

The chemotherapy of Plasmodium berghei. II. Antagonism of the action of drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1054-3589%2808%2960595-5

7 January 2021

28

74

845

Clarke

1962

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

27 March 2023

29

76

818

Clarke

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

Journal of Pharmacology and Experimental Therapeutics

27 March 2023

64

97

238

Greenberg

1949

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

Journal of Pharmacology and Experimental Therapeutics

27 March 2023

65

99

444

Greonberg

1950

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

Clinical Pharmacology & Therapeutics

27 March 2023

70

1

570

Hitchings

1960

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

27 March 2023

79

68

119

Kendall

1956

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

27 March 2023

99

9

139

Mazzoni

1967

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60595-5

27 March 2023

Identifiers

0 references

1 reference